reports
- Jonathan Moreland
RLI RLI CORP.
NEOG NEOGEN CORPORATION
LNDC LANDEC CORP.
LAKE LAKELAND INDUSTRIES INC.
CTSO CYTOSORBENTS
ASA ASA
WVE WAVE LIFE SCIENCES
OVLY OAK VALLEY BANCORP
FLWS 1-800-FLOWERS.COM CL A
FBK FB FINANCIAL CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ESQ ESQUIRE FINANCIAL HOLDINGS
MPB MID PENN BANCORP INC.
CIK CREDIT SUISSE ASSET MANAGEMENT INCOME FUND INC.
COGT COGINT
ETST INC.
LOOP EARTH SCIENCE TECH
FUND LOOP INDUSTRIES
ANIX ROYCE FOCUS TRUST
LBSRD INC.
ETON ANIXA BIOSCIENCES
GRX LIBERTY STAR URANIUM & METALS
MFON ETON PHARMACEUTICALS
PNTG THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ZYME MOBIVITY HOLDINGS CORP.
ALLY PENNANT GROUP
ENX ZYMEWORKS INC.
IBRX GMAC LLC
ACXP EATON VANCE NEW YORK MUNICIPAL BOND FUND
CVI IMMUNITYBIO INC
TLSI ACURX PHARMACEUTICALS INC
PCSA CVR ENERGY
PROP INC.
AVDL TRISALUS LIFE SCIENCES INC
MIO PROCESSA PHARMACEUTICALS INC
MXF PRAIRIE OPERATING CO.
SUNS AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
TXO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
AMST THE MEXICO FUND
WHLM INC.
IBIO SUNRISE REALTY TRUST
SDHY MORNINGSTAR PARTNERS
BATRK L.P.
MYCB AMESITE INC.
WILHELMINA INTERNATIONAL INC
IBIO INC.
PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
LIBERTY MEDIA CORPORATION
MY CITY BUILDERS
INC.
- Jonathan Moreland
Oak Valley Community Bank to Open New Branch in Lodi
Oak Valley Community Bank to Open New Branch in Lodi OAKDALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Oak Valley Community Bank, a wholly owned subsidiary of Oak Valley Bancorp (NASDAQ: OVLY) recently announced it has received regulatory approval to establish its 19th full-service branch. The new office will be located at 31 South School Street in downtown Lodi and is scheduled to open mid-2025. Established in 1991, Oak Valley Community Bank opened its first branch in San Joaquin County in 2005. The Lodi Branch will be the bank’s sixth location in the county and offer a full line o...
Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech C...
Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference NORWOOD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will be participating in the Guggenheim SMID Cap Biotech Conference, to be held February 5-6, 2025 in New York, NY Dr. Cohen will participate in analyst led fireside discussion and will attend one-on-one investor meetings. Guggenheim Securities SMID Cap Biotech ConferenceFormat: Fireside Chat and one-on-o...
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Prefer...
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock DALLAS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, and its board of directors declared a cash dividend of $14.375 per share of the 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), equivalent to $0.359375 per depositary share, each representing a 1/40th interest in a share of the Series B Preferred Stock. The depositary shares are traded on the NASDAQ under the symbol “TCBIO.” The...
NBT Bancorp Inc. Announces Full Year Net Income and Declares Cash Divi...
NBT Bancorp Inc. Announces Full Year Net Income and Declares Cash Dividend NORWICH, N.Y., Jan. 27, 2025 (GLOBE NEWSWIRE) -- NBT Bancorp Inc. (“NBT” or the “Company”) (NASDAQ: NBTB) reported net income and diluted earnings per share for the three and twelve months ended December 31, 2024. Net income for the three months ended December 31, 2024 was $36.0 million, or $0.76 per diluted common share, compared to $30.4 million, or $0.64 per diluted common share, for the three months ended December 31, 2023, and $38.1 million, or $0.80 per diluted common share, for the third quarter of 2024. Op...
Oak Valley Bancorp Reports 4th Quarter Results and Announces Cash Divi...
Oak Valley Bancorp Reports 4th Quarter Results and Announces Cash Dividend OAKDALE, Calif., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY) (the “Company”), the bank holding company for Oak Valley Community Bank and their Eastern Sierra Community Bank division, recently reported unaudited consolidated financial results. For the three months ended December 31, 2024, consolidated net income was $6,008,000 or $0.73 per diluted share (EPS), as compared to $7,324,000, or $0.89 EPS, for the prior quarter and $5,865,000, or $0.71 EPS for the same period a year ago. Consolidat...
Community West Bancshares Reports Earnings Results for the Quarter End...
FRESNO, Calif.--(BUSINESS WIRE)-- The Board of Directors of Community West Bancshares (“Company”) (NASDAQ: CWBC), the parent company of Community West Bank (“Bank”), reported today unaudited consolidated net income of $6,895,000, and diluted earnings per common share of $0.36 for the three months ended December 31, 2024, compared to $5,893,000 and $0.50 per diluted common share for the three months ended December 31, 2023. For the full release, please visit one of the following: Community West Bank Newsroom or CWBC Investor Relations . Company Overview Effective on April 1, 2024, Central ...
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 L...
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most Successful Mid-Cap Companies for the year 2025. Catalyst has ranked an impressive fifth out of 100 companies on the list. Last year Catalyst was ranked fourth in Forbes’ list of America’s Most Successful Small-Cap Companies, with this year’s ranking recognizing the comp...
Texas Capital Bancshares, Inc. Announces Fourth Quarter and Full Year ...
Texas Capital Bancshares, Inc. Announces Fourth Quarter and Full Year 2024 Results Income in fee areas of focus(1) increased 38% year-over-year Strong balance sheet growth with total deposits increasing 13% and total loans growing 10% year-over-year Book Value and Tangible Book Value(2) per share both increased 8% year-over-year, reaching record levels Capital ratios continue to be strong, including 11.4% CET1 and 15.4% Total Capital DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, announced operating re...
Texas Capital Elevates President & Chief Executive Officer Rob C. Holm...
Texas Capital Elevates President & Chief Executive Officer Rob C. Holmes to Additional Responsibilities as Chairman of the Board-Elect in Recognition of Transformation Progress DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced that its Board of Directors (the Board) unanimously elected Rob C. Holmes, Texas Capital’s President & Chief Executive Officer and existing Board Director, to also serve as Chairman of the Board immediately following the 2025 Annual Meeting of Stockholders. “The decision to ...
CVB Financial Corp. Reports Earnings for the Fourth Quarter and the Ye...
CVB Financial Corp. Reports Earnings for the Fourth Quarter and the Year Ended 2024 Fourth Quarter 2024 Net Earnings of $51 million, or $0.36 per share Return on Average Assets of 1.30%Net Interest Margin of 3.18% Full Year 2024 Net Earnings of $201 million, or $1.44 per share Return on Average Tangible Common Equity of 14.95% Ontario, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ:CVBF) and its subsidiary, Citizens Business Bank (the “Company”), announced earnings for the quarter and the year ended December 31, 2024. CVB Financial Corp. reported net income of $5...
Citizens Business Bank Donates $200,000 to Los Angeles Wildfire Relief...
Citizens Business Bank Donates $200,000 to Los Angeles Wildfire Relief Organizations ONTARIO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Citizens Business Bank (the “Bank”), a subsidiary of CVB Financial Corp. (NASDAQ: CVBF), announced today that the Bank has committed $200,000 to local community organizations directed specifically to wildfire relief.The Bank’s $200,000 donation will be distributed to four organizations in Los Angeles County, with each receiving $50,000. The recipient organizations include Foothill Unity Center, Union Station Homeless Services, Pasadena Community Foundatio...
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched F...
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today reported that its sub-licensee in Japan, DyDo Pharma, Inc., ("DyDo") has launched FIRDAPSE® (amifampridine) Tablets 10 mg in Japan for the indication of improving muscle weakness in patients living with Lambert-Eaton...
Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 202...
Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2024 Operating Results DALLAS, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the full year and fourth quarter of 2024 before market on Thursday, January 23, 2025. Executive management will host a conference call and webcast to discuss full year and fourth quarter 2024 operating results on Thursday, January 23, 2025, at 9:00 a.m. EDT. Participants may pre-register for the call by visit...
Texas Capital Securities Initiates Equity Research Coverage
Texas Capital Securities Initiates Equity Research Coverage Coverage begins with 38 companies in the U.S. upstream, agribusiness, biofuel and energy adjacent sectors DALLAS, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Texas Capital Securities, a subsidiary of Texas Capital Bancshares, Inc. (NASDAQ: TCBI), today announced it has initiated coverage of 38 companies in the energy and energy-adjacent sectors. The newly formed Equity Research team will enhance the firm’s product and service capabilities, investment insights and dedicated coverage of the energy industry and adjacent sectors, while also ...
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifamprid...
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035 CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that the Company and its licensor SERB S.A. (...
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from W...
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025 NORWOOD, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced data from its first-in-human dose escalation clinical study conducted in the United States and the United Kingdom (“Western study”) of CRB-701 (SYS6002) will be presented at the (ASCO GU), to be held in San Francisco, CA February 13–15, 2025. The poster is titled Phase 1 Dose-Escalation Study of Next-Genera...
Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healt...
Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference NORWOOD, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will be participating in the 43rd Annual J.P. Morgan Healthcare Conference, to be held January 13-16, 2025 in San Francisco, CA. Dr. Cohen will be presenting and attending investor meetings. Format: Presentation and one-on-one investor meetingsPresentation Date: January 16, 2025Presentation Time 11...
Texas Capital Appoints Aimee Williams-Ramey to Serve as Chief Human Re...
Texas Capital Appoints Aimee Williams-Ramey to Serve as Chief Human Resources Officer DALLAS, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced the appointment of Aimee Williams-Ramey as its Chief Human Resources Officer (CHRO), effective immediately. Williams-Ramey now reports directly to Texas Capital’s President & Chief Executive Officer Rob C. Holmes and serves as a member of the firm’s Operating Committee. Williams-Ramey joined Texas Capital in May 2024 as Deputy General Counsel and Assistant Corpora...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.